The use of pharmaceutical inhibitor AGI-5198 with IDH mutant patient-derived cultured glioma cells has demonstrated the downregulation of essential epigenetic reader Zinc Finger MYND-Type Containing 8 (ZMYND8) [122]. This evidence concerns the gene IDH2 and central nervous system cancer.